Everolimus-Eluting Coronary Artery Stent Frame - Vietnam Registration 2301266ĐKLH/BYT-HTTB
Access comprehensive regulatory information for Everolimus-Eluting Coronary Artery Stent Frame in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại D medical device is registered under number 2301266ĐKLH/BYT-HTTB and manufactured by Nano Therapeutics Pvt. Ltd..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
2301266ĐKLH/BYT-HTTB
000.00.04.G18-220927-0004
EVERMAX - Everolimus Eluting Coronary Stent System
EM20008; EM20012; EM20016; EM20020; EM20024; EM20028; EM20032; EM20036; EM20040; EM20044; EM20048; EM20050; EM20052 EM22508; EM22512; EM22516; EM22520; EM22524; EM22528; EM22532; EM22536; EM22540; EM22544; EM22548; EM22550; EM22552 EM25008; EM25012; EM25016; EM25020; EM25024; EM25028; EM25032; EM25036; EM25040; EM25044; EM25048; EM25050; EM25052 EM27508; EM27512; EM27516; EM27520; EM27524; EM27528; EM27532; EM27536; EM27540; EM27544; EM27548; EM27550; EM27552 EM30008; EM30012; EM30016; EM30020; EM30024; EM30028; EM30032; EM30036; EM30040; EM30044; EM30048; EM30050; EM30052 EM37508; EM37512; EM37516; EM37520; EM37524; EM37528; EM37532; EM37536; EM37540; EM37544; EM37548; EM37550; EM37552 EM40008; EM40012; EM40016; EM40020; EM40024; EM40028; EM40032; EM40036; EM40040; EM40044; EM40048; EM40050; EM40052 EM45008; EM45012; EM45016; EM45020; EM45024; EM45028; EM45032; EM45036; EM45040; EM45044; EM45048; EM45050; EM45052
Technical Details
The Everolimus-coated Evermax stent is indicated for the treatment of patients who are candidates for percutaneous coronary intervention (PCI). The Everolimus-coated Evermax stent is indicated to improve the diameter of the coronary artery in patients with symptomatic ischemia due to chronic total occlusions (CTO) of the coronary arteries with a length ≤ 52 mm and a vessel diameter ranging from 2.25 to 4.50 mm, and who are candidates for percutaneous coronary intervention (PCI).
Dates and Status
Oct 11, 2023